| Product NDC: | 37000-736 |
| Proprietary Name: | Nioxin Scalp Treatment System 4 |
| Non Proprietary Name: | Ensulizole and Sulisobenzone |
| Active Ingredient(s): | 41.2; 16.48 mg/mL; mg/mL & nbsp; Ensulizole and Sulisobenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 37000-736 |
| Labeler Name: | Procter & Gamble Manufacturing Company |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110501 |
| Package NDC: | 37000-736-40 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (37000-736-40) > 40 mL in 1 BOTTLE, PLASTIC |
| NDC Code | 37000-736-40 |
| Proprietary Name | Nioxin Scalp Treatment System 4 |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (37000-736-40) > 40 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 37000-736 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Ensulizole and Sulisobenzone |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20110501 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Procter & Gamble Manufacturing Company |
| Substance Name | ENSULIZOLE; SULISOBENZONE |
| Strength Number | 41.2; 16.48 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes |